HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

6th Edition of

International Public Health Conference

March 15-17, 2027 | Singapore

Clinical Trials

Clinical Trials

Clinical trials are prospective biomedical or behavioural research studies involving human subjects that aim to provide answers to particular questions about biomedical or behavioural interventions. These include both established and novel treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) as well as interventions that have already been tried and tested but still require more research and comparison. Data on dosage, safety, and effectiveness are produced by clinical trials. In the nation where therapy approval is sought, they are only carried out after receiving approval from the health authority or ethics committee. These authorities are in charge of evaluating the trial's risk/benefit ratio; their approval merely permits the trial to proceed and does not imply that the therapy is "safe" or effective. In small pilot studies, researchers first enrol volunteers or patients, depending on the product type and stage of development.

Committee Members
Speaker at IPHC 2027 - Kenneth R Pelletier

Kenneth R Pelletier

University of California, United States
Speaker at IPHC 2027 - Thomas J Webster

Thomas J Webster

Brown University, United States
Speaker at IPHC 2027 - Anyou Wang

Anyou Wang

DIFIBER LLC, United States
IPHC 2027 Speakers
Speaker at IPHC 2027 - Vijayan Gurumurthy Iyer

Vijayan Gurumurthy Iyer

Techno-Economic-Environmental Study and Check Consultancy Services
Speaker at IPHC 2027 - K. R. Aneja

K. R. Aneja

Kurukshetra University
Speaker at IPHC 2027 - Fred Moss

Fred Moss

Founder, Welcome to Humanity Grass Valley, California
Speaker at IPHC 2027 - Misgana E Woldemeskel

Misgana E Woldemeskel

The George Washington University

Submit your abstract Today

YouTube
WhatsAppWhatsApp